HCV-Host Interactions During Antiviral Therapy

抗病毒治疗期间 HCV 与宿主的相互作用

• 批准号: 8292304
• 负责人: STEPHEN J. POLYAK
• 金额: $ 25.09万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-08-01 至 2012-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8292304
• 关键词: Address; Affect; African American; American; Antiviral Agents; Antiviral Response; Antiviral Therapy; Blood; Brazil; Chronic Hepatitis C; Clinic; Clinical; Clinical Trials; DNA; Data; Developing Countries; Ethnic Origin; Europe; European; Failure; Fred Hutchinson Cancer Research Center; Gene Expression; Gene Expression Profile; Genes; Genetic; Genetic Polymorphism; Genetic Variation; Genotype; Hepatic; Hepatitis C; Hepatitis C virus; Hour; Immune response; Industry; Injection of therapeutic agent; Institutional Review Boards; Integration Host Factors; Interferons; Interleukins; Kinetics; Lead; Learning; Liver; Measures; Minority; Monitor; Outcome; Patients; Peripheral; Pharmaceutical Preparations; Phase; Population; Population Genetics; Population Heterogeneity; Positioning Attribute; Preparation; Production; Research Personnel; Research Proposals; Resistance; Ribavirin; Sampling; Shapes; Signal Transduction; Signal Transduction Pathway; Single Nucleotide Polymorphism; South American; System; Systems Biology; Therapeutic; Treatment outcome; Universities; Viral; Viral Load result; Virus; Washington; Work; base; burden of illness; cohort; effective therapy; experience; improved; interferon therapy; novel; resistant strain; response; standard of care; therapy outcome; treatment strategy; viral RNA; virology